Mengbing Lin, Shengliang Shi, Jian Zhang, Cheng Min Yang, Jiefeng Luo
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of ocrelizumab in people with relapsing‐remitting multiple sclerosis (RRMS) or primary progressive multiple sclerosis (PPMS).
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy and safety of ocrelizumab in people with relapsing‐remitting multiple sclerosis (RRMS) or primary progressive multiple sclerosis (PPMS).
Key concepts: Ocrelizumab, Multiple sclerosis, Medicine, Relapsing remitting, Intervention (counseling), Protocol (science), Physical therapy, Oncology